Sex-specific differences in diabetes prevention: a systematic review and meta-analysis

Anna Glechner, Jürgen Harreiter, Gerald Gartlehner, Sonja Rohleder, Alexander Kautzky, Jaakko Tuomilehto, Megan Van Noord, Angela Kaminski-Hartenthaler, Alexandra Kautzky-Willer

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Aims/hypothesis: In people with prediabetes, lifestyle interventions and glucose-lowering medications are effective in preventing the progression to type 2 diabetes. It is unclear whether differences in treatment effects between men and women need to be taken into consideration when choosing a preventive strategy for an individual person.

Methods: We systematically searched PubMed, the Cochrane Library, EMBASE, CINAHL, Web of Science, and reference lists of pertinent review articles from 1980 to June 2013. We conducted random effects meta-analyses of published and unpublished data to determine differences of treatment effects between men and women.

Conclusions/interpretation: Our study emphasises the importance of preventive interventions in people with prediabetes and indicates no differences of beneficial preventive effects on the incidence of type 2 diabetes and weight gain between men and women.

Results: Twelve randomised control trials (RCTs) provided sex-specific information on treatment effects. Compared with usual care, men and women who received lifestyle interventions had a lower rate of progression to type 2 diabetes (RR 0.60 [95% CI 0.35, 1.05] after 1 year; RR 0.63 [95% CI 0.51, 0.79] after 3 years); greater weight reduction (−2.45 kg; [95% CI −3.56, −1.33 kg] after 3 years); and greater reductions of fasting plasma glucose (−0.31 mmol/l [95% CI −0.48, −0.15] after 3 years) and 2 h post-challenge-glucose (−0.68 mmol/l [95% CI −1.03, −0.34] after 3 years). No statistically significant differences in treatment effects between men and women were apparent for any outcomes (p values of all comparisons ≥0.09).

Original languageEnglish (US)
Pages (from-to)242-254
Number of pages13
JournalDiabetologia
Volume58
Issue number2
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Sex Characteristics
Meta-Analysis
Type 2 Diabetes Mellitus
Prediabetic State
Glucose
Life Style
Therapeutics
PubMed
Libraries
Weight Gain
Weight Loss
Fasting
Incidence

Keywords

  • Diabetes prevention
  • Glucose-lowering agents
  • Lifestyle intervention
  • Meta-analysis
  • Prediabetes
  • Sex
  • Systematic review

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Glechner, A., Harreiter, J., Gartlehner, G., Rohleder, S., Kautzky, A., Tuomilehto, J., ... Kautzky-Willer, A. (2015). Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia, 58(2), 242-254. https://doi.org/10.1007/s00125-014-3439-x

Sex-specific differences in diabetes prevention : a systematic review and meta-analysis. / Glechner, Anna; Harreiter, Jürgen; Gartlehner, Gerald; Rohleder, Sonja; Kautzky, Alexander; Tuomilehto, Jaakko; Van Noord, Megan; Kaminski-Hartenthaler, Angela; Kautzky-Willer, Alexandra.

In: Diabetologia, Vol. 58, No. 2, 01.01.2015, p. 242-254.

Research output: Contribution to journalArticle

Glechner, A, Harreiter, J, Gartlehner, G, Rohleder, S, Kautzky, A, Tuomilehto, J, Van Noord, M, Kaminski-Hartenthaler, A & Kautzky-Willer, A 2015, 'Sex-specific differences in diabetes prevention: a systematic review and meta-analysis', Diabetologia, vol. 58, no. 2, pp. 242-254. https://doi.org/10.1007/s00125-014-3439-x
Glechner A, Harreiter J, Gartlehner G, Rohleder S, Kautzky A, Tuomilehto J et al. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia. 2015 Jan 1;58(2):242-254. https://doi.org/10.1007/s00125-014-3439-x
Glechner, Anna ; Harreiter, Jürgen ; Gartlehner, Gerald ; Rohleder, Sonja ; Kautzky, Alexander ; Tuomilehto, Jaakko ; Van Noord, Megan ; Kaminski-Hartenthaler, Angela ; Kautzky-Willer, Alexandra. / Sex-specific differences in diabetes prevention : a systematic review and meta-analysis. In: Diabetologia. 2015 ; Vol. 58, No. 2. pp. 242-254.
@article{222a46fba4c0448db99c24aaac354b3d,
title = "Sex-specific differences in diabetes prevention: a systematic review and meta-analysis",
abstract = "Aims/hypothesis: In people with prediabetes, lifestyle interventions and glucose-lowering medications are effective in preventing the progression to type 2 diabetes. It is unclear whether differences in treatment effects between men and women need to be taken into consideration when choosing a preventive strategy for an individual person.Methods: We systematically searched PubMed, the Cochrane Library, EMBASE, CINAHL, Web of Science, and reference lists of pertinent review articles from 1980 to June 2013. We conducted random effects meta-analyses of published and unpublished data to determine differences of treatment effects between men and women.Conclusions/interpretation: Our study emphasises the importance of preventive interventions in people with prediabetes and indicates no differences of beneficial preventive effects on the incidence of type 2 diabetes and weight gain between men and women.Results: Twelve randomised control trials (RCTs) provided sex-specific information on treatment effects. Compared with usual care, men and women who received lifestyle interventions had a lower rate of progression to type 2 diabetes (RR 0.60 [95{\%} CI 0.35, 1.05] after 1 year; RR 0.63 [95{\%} CI 0.51, 0.79] after 3 years); greater weight reduction (−2.45 kg; [95{\%} CI −3.56, −1.33 kg] after 3 years); and greater reductions of fasting plasma glucose (−0.31 mmol/l [95{\%} CI −0.48, −0.15] after 3 years) and 2 h post-challenge-glucose (−0.68 mmol/l [95{\%} CI −1.03, −0.34] after 3 years). No statistically significant differences in treatment effects between men and women were apparent for any outcomes (p values of all comparisons ≥0.09).",
keywords = "Diabetes prevention, Glucose-lowering agents, Lifestyle intervention, Meta-analysis, Prediabetes, Sex, Systematic review",
author = "Anna Glechner and J{\"u}rgen Harreiter and Gerald Gartlehner and Sonja Rohleder and Alexander Kautzky and Jaakko Tuomilehto and {Van Noord}, Megan and Angela Kaminski-Hartenthaler and Alexandra Kautzky-Willer",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s00125-014-3439-x",
language = "English (US)",
volume = "58",
pages = "242--254",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Sex-specific differences in diabetes prevention

T2 - a systematic review and meta-analysis

AU - Glechner, Anna

AU - Harreiter, Jürgen

AU - Gartlehner, Gerald

AU - Rohleder, Sonja

AU - Kautzky, Alexander

AU - Tuomilehto, Jaakko

AU - Van Noord, Megan

AU - Kaminski-Hartenthaler, Angela

AU - Kautzky-Willer, Alexandra

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Aims/hypothesis: In people with prediabetes, lifestyle interventions and glucose-lowering medications are effective in preventing the progression to type 2 diabetes. It is unclear whether differences in treatment effects between men and women need to be taken into consideration when choosing a preventive strategy for an individual person.Methods: We systematically searched PubMed, the Cochrane Library, EMBASE, CINAHL, Web of Science, and reference lists of pertinent review articles from 1980 to June 2013. We conducted random effects meta-analyses of published and unpublished data to determine differences of treatment effects between men and women.Conclusions/interpretation: Our study emphasises the importance of preventive interventions in people with prediabetes and indicates no differences of beneficial preventive effects on the incidence of type 2 diabetes and weight gain between men and women.Results: Twelve randomised control trials (RCTs) provided sex-specific information on treatment effects. Compared with usual care, men and women who received lifestyle interventions had a lower rate of progression to type 2 diabetes (RR 0.60 [95% CI 0.35, 1.05] after 1 year; RR 0.63 [95% CI 0.51, 0.79] after 3 years); greater weight reduction (−2.45 kg; [95% CI −3.56, −1.33 kg] after 3 years); and greater reductions of fasting plasma glucose (−0.31 mmol/l [95% CI −0.48, −0.15] after 3 years) and 2 h post-challenge-glucose (−0.68 mmol/l [95% CI −1.03, −0.34] after 3 years). No statistically significant differences in treatment effects between men and women were apparent for any outcomes (p values of all comparisons ≥0.09).

AB - Aims/hypothesis: In people with prediabetes, lifestyle interventions and glucose-lowering medications are effective in preventing the progression to type 2 diabetes. It is unclear whether differences in treatment effects between men and women need to be taken into consideration when choosing a preventive strategy for an individual person.Methods: We systematically searched PubMed, the Cochrane Library, EMBASE, CINAHL, Web of Science, and reference lists of pertinent review articles from 1980 to June 2013. We conducted random effects meta-analyses of published and unpublished data to determine differences of treatment effects between men and women.Conclusions/interpretation: Our study emphasises the importance of preventive interventions in people with prediabetes and indicates no differences of beneficial preventive effects on the incidence of type 2 diabetes and weight gain between men and women.Results: Twelve randomised control trials (RCTs) provided sex-specific information on treatment effects. Compared with usual care, men and women who received lifestyle interventions had a lower rate of progression to type 2 diabetes (RR 0.60 [95% CI 0.35, 1.05] after 1 year; RR 0.63 [95% CI 0.51, 0.79] after 3 years); greater weight reduction (−2.45 kg; [95% CI −3.56, −1.33 kg] after 3 years); and greater reductions of fasting plasma glucose (−0.31 mmol/l [95% CI −0.48, −0.15] after 3 years) and 2 h post-challenge-glucose (−0.68 mmol/l [95% CI −1.03, −0.34] after 3 years). No statistically significant differences in treatment effects between men and women were apparent for any outcomes (p values of all comparisons ≥0.09).

KW - Diabetes prevention

KW - Glucose-lowering agents

KW - Lifestyle intervention

KW - Meta-analysis

KW - Prediabetes

KW - Sex

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84925510955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925510955&partnerID=8YFLogxK

U2 - 10.1007/s00125-014-3439-x

DO - 10.1007/s00125-014-3439-x

M3 - Article

C2 - 25465437

AN - SCOPUS:84925510955

VL - 58

SP - 242

EP - 254

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 2

ER -